1. Summary Information

 

 

Country

India

Company Name

SAMARTH PHARMA PRIVATE LIMITED

Principal Name 1

Mr. Kanjibhai Parmar

Status

Satisfactory

Principal Name 2

Mr. Chittozi Radhakrishnan

 

 

Registration #

11-110616

Street Address

Samarth House, Ram Mandir Road, Opposite Movie Star Theatre, Goregaon (West), Mumbai 400 104, Maharashtra, India

Established Date

11.09.1997

SIC Code

--

Telephone#

91-22-66959186 / 28731021 / 28727930 / 26763735/ 3634

Business Style 1

Trader

Fax #

91-22-66959185 / 28724234

Business Style 2

Exporter

Homepage

www.samarthpharma.com

Product Name 1

Cardiovascular Drugs

# of employees

60 (Approximately)

Product Name 2

Anti-neoplastic

Paid up capital

Rs. 2,500,000/-

Product Name 3

Anti-muscarinic agent

Shareholders

Others ( 100%)

Banking

State Bank of India

Public Limited Corp.

NO

Business Period

13 Years

IPO

NO

International Ins.

-

Public Enterprise

NO

Rating

BA

Related Company

Relation

Country

Company Name

CEO

Note

-

 

2. Summary Financial Statement

Balance Sheet as of

31.03.2010

(Unit: Indian Rs.)

Assets

Liabilities

Current Assets

24,095,000

Current Liabilities

9,803,000

Inventories

6,088,000

Long-term Liabilities

--

Fixed Assets

17,023,000

Other Liabilities

61,000

Deferred Assets

--

Total Liabilities

9,864,000

Invest& other Assets

132,874,000

Retained Earnings

167,716,000

 

 

Net Worth

170,216,000

Total Assets

180,080,000

Total Liab. & Equity

180,080,000

 Total Assets

(Previous Year)

288,552,000

 

 

P/L Statement as of

31.03.2010

(Unit: Indian Rs.)

Sales

55,483,000

Net Profit

10,256,000

Sales(Previous yr)

NA

Net Profit(Prev.yr)

20,940,000

 

MIRA INFORM REPORT

 

 

Report Date :

07.03.2011

 

IDENTIFICATION DETAILS

 

Name :

SAMARTH PHARMA PRIVATE LIMITED

 

 

Registered Office :

Ram Mandir Road, Goregaon (West), Mumbai 400 104, Maharashtra

 

 

Country :

India

 

 

Financials (as on) :

31.03.2010

 

 

Date of Incorporation :

11.09.1997

 

 

Com. Reg. No.:

11-110616

 

 

CIN No.:

[Company Identification No.]

U99999MH1997PTC110616

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

MUMS23813G

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Trader, Exporter and Importer of Pharmaceutical Products.

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (45)

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 681000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually Correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having satisfactory track. Trade relations are reported as fair. Business is active. Payments are reported to be usually correct and as per commitments.

 

The company can be considered normal for business dealings at usual trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – April 1, 2010

 

Country Name

Previous Rating

(31.12.2009)

Current Rating

(01.04.2010)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

 

INFORMATION PARTED BY

 

Name :

Mr. Kanji Vai

Designation :

Accounts Manager

 

 

 

 

LOCATIONS

 

Registered Office :

Ram Mandir Road, Goregaon (West), Mumbai 400 104, Maharashtra, india

Tel. No.:

91-22-66959186 / 28731021 / 28727930 / 26763735/ 3634

Fax No.:

91-22-66959185 / 28724234

E-Mail :

info@samarthpharma.com

samarth@samarthpharma.com

sales@samarthpharma.com

Website:

www.samarthpharma.com

Area :

1500 Sq. ft.

Location :

Rented

 

 

 

 

DIRECTORS

 

As on : 30.09.2010

 

Name :

Mr. Kanjibhai Parmar

Designation :

Director

Address :

10, Bhukhannan Sitaram Chawl, Janu Compound, Malad (East), Mumbai, Maharashtra, India

Date of Birth/Age :

02.05.1958

Qualification :

Graduate

Date of Appointment :

14.06.2004

 

 

Name :

Mr. Chittozi Radhakrishnan

Designation :

Director

Address :

F-003, Geeta Nagar, Phase-Ill, Mlra Road, Mumbai – 401 107, Maharashtra, India

Date of Birth/Age :

01.06.1952

Qualification :

Graduate

Date of Appointment :

11.09.1997

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on : 30.09.2010

 

Names of Shareholders

 

No. of Shares

 

Chittozi Radhakrishnan

 

300

Pranav Shah

 

74000

Rajiv Shah

 

74000

Sohini Shah

 

52300

Gunvantlal Shah

 

49400

 

 

 

Total

 

250000

 

As on : 30.09.2010

 

Equity Share Breakup

 

Percentage of Holding

Category

 

 

Others

 

100.00

 

 

 

 

 

BUSINESS DETAILS

 

Line of Business :

Trader, Exporter and Importer of Pharmaceutical Products. 

 

 

Products :

  • Cardiovascular Drugs
  • Anti-neoplastic
  • Anti-muscarinic agent
  • Diagnostic agents
  • Laxative
  • Anti-inflammatory analgesic antipyretic
  • Antacid antispasmodic ulcer healing drug
  • Sclerosants
  • Anthelmintic
  • Antibiotics / anti-microbials / quinolones  
  • Mucolytic agent
  • Anti-tuberculosis
  • Antidotes to poisoning
  • Nephrology drug
  • Anxiolytic and anti - convulsant
  • Anti-cold
  • Psychotropic drugs and sedative
  • Haemostatic agent
  • Antibiotics and cephalosporins
  • Anti-asthmatic

 

 

 

 

GENERAL INFORMATION

 

Customers :

Pharma Companies

 

 

No. of Employees :

60 (Approximately)

 

 

Bankers :

  • State Bank of India, Jogeshwari (West) Branch, Mumbai, Maharashtra, India
  • HDFC Bank, Goregaon (West) Branch, Mumbai 

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

Satish Soni and Company

Chartered Accountants

Address :

15/ 1, 2nd Floor , Metro House, Colaba, Mumbai-400 001, Maharashtra, India

Tel. No.:

91-22-32903287

Mobile No.:

91-9322693989

Fax No.:

91-22-22876467

E-Mail :

scsoni@gmail.com

 

 

 

 

CAPITAL STRUCTURE

 

As on : 31.03.2010

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

250000

Equity Shares

Rs.10/- each

Rs.2.500 millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

250000

Equity Shares

Rs.10/- each

Rs.2.500 millions

 

 

 

 

 

 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2010

31.03.2009

31.03.2008

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

2.500

2.500

2.500

2] Share Application Money

0.000

0.700

0.700

3] Reserves & Surplus

167.716

158.485

137.544

4] (Accumulated Losses)

0.000

0.000

0.000

NETWORTH

170.216

161.685

140.744

LOAN FUNDS

 

 

 

1] Secured Loans

0.000

0.000

0.000

2] Unsecured Loans

0.000

0.000

0.000

TOTAL BORROWING

0.000

0.000

0.000

DEFERRED TAX LIABILITIES

0.061

1.586

1.480

 

 

 

 

TOTAL

170.277

163.271

142.224

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

17.023

10.310

8.261

Capital work-in-progress

0.000

0.000

0.000

 

 

 

 

INVESTMENT

132.874

27.680

104.400

DEFERREX TAX ASSETS

0.000

0.000

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

6.088
5.910

14.748

 

Sundry Debtors

6.092
2.438

4.728

 

Cash & Bank Balances

9.773
115.824

10.369

 

Other Current Assets

0.000
0.000

0.000

 

Loans & Advances

8.230
5.505

34.446

Total Current Assets

30.183
129.677

64.291

Less : CURRENT LIABILITIES & PROVISIONS

 
 

 

 

Current Liabilities

4.830
1.972

2.174

 

Provisions

4.973
2.424

32.554

Total Current Liabilities

9.803
4.396

34.728

Net Current Assets

20.380
125.281

29.563

 

 

 

 

MISCELLANEOUS EXPENSES

0.000

0.000

0.000

 

 

 

 

TOTAL

170.277

163.271

142.224

 


PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2010

31.03.2009

31.03.2008

 

SALES

 

 

 

Income

55.483

NA

NA

 

 

Other Income

 

 

 

 

 

TOTAL                                     (A)

55.483

NA

NA

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Office Expenses

 

 

 

 

Administrative Expenses

 

 

 

 

 

Advertising Expenses

45.226

NA

NA

 

 

Interest

 

 

 

 

 

Depreciation

 

 

 

 

 

TOTAL                                     (B)

45.226

NA

NA

 

 

 

 

 

 

PROFIT BEFORE TAX (E-F)                               (G)

10.256

21.994

4.403

 

 

 

 

 

Less

TAX                                                                  (I)

0.000

1.054

1.578

 

 

 

 

 

 

PROFIT AFTER TAX (G-I)                                  (J)

10.256

20.940

2.825

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

Export Earnings

NA

0.660

NA

 

TOTAL EARNINGS

NA

0.660

NA

 

 

 

 

 

 

Earnings Per Share (Rs.)

Nil

83.76

NA

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2010

31.03.2009

31.03.2008

PAT / Total Income

(%)

18.48

--

--

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

18.48

--

--

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

21.72
15.71

6.07

 

 

 
 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.06
0.14

0.03

 

 

 
 

 

Debt Equity Ratio

(Total Liability/Networth)

 

0.05
0.03

0.25

 

 

 
 

 

Current Ratio

(Current Asset/Current Liability)

 

3.07
29.50

1.85

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Form 8

 

Bankers Charges Report as per Registry

 

Name of the company

SAMARTH PHARMA PRIVATE LIMITED

Presented By

Jointly company and charge holder

1) Date and description of instrument creating the change

General agreement for grant of small industrial advances and hypothecation of movables, book debts and other assets dated 21.03.2000

2) Amount secured by the charge/amount owing on the securities of charge

Rs.2.700 millions

3) Short particular of the property charged. If the property acquired is subject to charge, date of the acquired of the property should be given

All present and future goods, book debts, movables and other assets including documents of title to goods and other assets, such as outstanding moneys, receivables, claims, bills, invoices, documents, contracts, engagement, securities, investments and right and the present machinery and all future machinery belonging to or in the possession or under the control of the company wherever lying stored and kept and whether in possession of the company or of the Bank or of any third party whether in India or elsewhere through out the world including all such goods movables and other assets as may be in course of shipment, transit or delivery. 

4) Gist of the terms and conditions and extent and operation of the charge.

1. Interest payable as may be decided by the Bank from time to time.

2. Margin to be maintained at such rated as stipulated by the Bank from time to time.

3. Security created by way of first charge and to cover the principal amount together with interest, charges, costs, expenses etc.  

5) Name and Address and description of the person entitled to the charge.

State Bank of India, Jogeshwari (West) Branch, Mumbai, Maharashtra, India

6) Date  and brief description of instrument modifying the charge

Not Applicable

7) Particulars of modifications specifying the terms and conditions or the extent of operations of the charge in which modification is made and the details of the modification.

Not Applicable 

 

 

 

 

 

 

 

 

 

 

 

Fixed Assets :

 

  • Plant and Machinery
  • Factory Building
  • Furniture And Fixture
  • Office Equipments
  • Car
  • Computer And Printer
  • Khopoli Factory

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                              None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

 

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs. 44.99

UK Pound

1

Rs. 73.23

Euro

1

Rs. 62.80

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

5

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

5

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

5

--PROFITABILIRY

1~10

5

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

5

--RESERVES

1~10

5

--CREDIT LINES

1~10

5

--MARGINS

-5~5

-

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

NO

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

45

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

 

 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

-

NB

                                       New Business

-

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.